Literature DB >> 9121121

Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice.

E Mizoguchi1, A Mizoguchi, A K Bhan.   

Abstract

Chronic colitis develops spontaneously in mice mutant for T-cell receptor alpha (TCR alpha) genes maintained in pathogen-free conditions. Our previous studies indicate that the cytokine imbalance caused by a lack of TCR alpha beta + T cells may be associated with the development of chronic colitis in TCR alpha-mutant (TCR alpha -/-) mice. The histologic changes of chronic colitis are recognizable by 3 to 4 months of age and are characterized by marked crypt cell hyperplasia and the presence of an inflammatory cell infiltrate. Because early events in the development of chronic colitis may be important in the pathogenesis of the disorder, we investigated the changes in the colon at a time when chronic colitis was not yet histologically recognizable. In vivo labeling with 5-bromo-2'-deoxyuridine revealed increased epithelial proliferation in the crypts by 6 to 8 weeks of age. There was an increase in number of T cells in the colon of TCR alpha -/- mice compared with that in TCR alpha +/- (heterozygous TCR alpha-mutant) mice after 6 weeks of age. The predominant T-cell subsets were CD4+, TCR alpha- beta +, and TCR gamma delta + cells. Reverse transcription-PCR and immunohistochemistry of the colonic mucosa obtained from TCR alpha -/- mice (> 6 weeks old) showed a marked increase of IL-1 alpha and IL-1 beta but not of TNF alpha or transforming growth factor beta-1 compared with TCR alpha +/- mice. In vivo neutralization of IL-1 alpha or IL-1 beta by specific mAb suppressed colonic epithelial proliferation and decreased colonic mucosal T-cell infiltration in 8-week-old TCR alpha -/- mice. These results provide direct evidence that overproduction of IL-1 alpha and IL-1 beta in the colonic mucosa may play an important role in the early stages of development of chronic colitis in TCR alpha -/- mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121121

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

Review 1.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

2.  Intestinal heat shock protein 110 regulates expression of CD1d on intestinal epithelial cells.

Authors:  Sean P Colgan; Richard S Pitman; Takashi Nagaishi; Atsushi Mizoguchi; Emiko Mizoguchi; Lloyd F Mayer; Ling Shao; R Balfour Sartor; John R Subjeck; Richard S Blumberg
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

3.  Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.

Authors:  Masaru Yoshida; Kanna Kobayashi; Timothy T Kuo; Lynn Bry; Jonathan N Glickman; Steven M Claypool; Arthur Kaser; Takashi Nagaishi; Darren E Higgins; Emiko Mizoguchi; Yoshio Wakatsuki; Derry C Roopenian; Atsushi Mizoguchi; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

4.  Chitin microparticles for the control of intestinal inflammation.

Authors:  Katsuya Nagatani; Sen Wang; Victoria Llado; Cindy W Lau; Zongxi Li; Atsushi Mizoguchi; Cathryn R Nagler; Yoshimi Shibata; Hans-Christian Reinecker; J Rodrigo Mora; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2012-01-12       Impact factor: 5.325

5.  The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.

Authors:  Atsushi Nishida; Cindy W Lau; Mei Zhang; Akira Andoh; Hai Ning Shi; Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

6.  Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia.

Authors:  Chun-Chuan Chen; Joel Pekow; Victoria Llado; Manasa Kanneganti; Cindy W Lau; Atsushi Mizoguchi; Mari Mino-Kenudson; Marc Bissonnette; Emiko Mizoguchi
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

7.  Lymphoid hyperplasia in transgenic mice over-expressing a secreted form of the human interleukin-1beta gene product.

Authors:  O Björkdahl; P Akerblad; A Gjörloff-Wingren; T Leanderson; M Dohlsten
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

8.  A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease.

Authors:  Hidetoshi Takedatsu; Keiichi Mitsuyama; Shinichi Mochizuki; Teppei Kobayashi; Kazuo Sakurai; Hiroshi Takeda; Yoshihide Fujiyama; Yoshikazu Koyama; Jun Nishihira; Michio Sata
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

9.  High- and low-affinity single-peptide/MHC ligands have distinct effects on the development of mucosal CD8alphaalpha and CD8alphabeta T lymphocytes.

Authors:  C N Levelt; Y P de Jong; E Mizoguchi; C O'Farrelly; A K Bhan; S Tonegawa; C Terhorst; S J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice.

Authors:  Anna Lyubimova; John J Garber; Geeta Upadhyay; Andrey Sharov; Florentina Anastasoaie; Vijay Yajnik; George Cotsarelis; Gian Paolo Dotto; Vladimir Botchkarev; Scott B Snapper
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.